The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive-A randomized controlled trial.
Marcus-Hillert Schultze-MosgauBarbara SchüttCorinna DraegerManuela CasjensStephanie LoewenTorsten ZimmermannBeate RohdePublished in: British journal of clinical pharmacology (2020)
The SPRM VPR interfered with the pharmacodynamic effects of the COC. Therefore, full contraceptive effectiveness cannot be assumed without final judgement by a Pearl index study. Women on SPRMs should be advised to use nonhormonal contraception methods.